This inventor holds 2 USPTO granted patents. Top assignee: Mitsubishi Chemical Corporation. Active years: 2000-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kanagawa-ken, JP (2000)
- Kanagawa, JP (2001)
Company Filing History:
Years Active: 2000-2001
Title: Naoko Inoue: Innovator in Antiviral Compounds
Introduction
Naoko Inoue is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of antiviral research, particularly through her innovative work on phosphonate nucleotide derivatives. With a total of 2 patents, her inventions are paving the way for new therapeutic options.
Latest Patents
Inoue's latest patents focus on phosphonate nucleotide derivatives, which are compounds that exhibit antiviral activity. One of her notable inventions is a phosphonate-nucleotide ester derivative, which has shown excellent antiviral and antineoplastic activity. These compounds can be administered orally, making them a promising option for treatment. The general formula for these compounds includes various substituents that enhance their efficacy.
Career Highlights
Naoko Inoue is affiliated with Mitsubishi Chemical Corporation, where she continues to advance her research in antiviral compounds. Her work is characterized by a commitment to developing effective treatments that can improve patient outcomes.
Collaborations
Inoue collaborates with esteemed colleagues, including Hideaki Takashima and Masaru Ubasawa, to further her research and development efforts. Their combined expertise contributes to the innovative solutions being developed at Mitsubishi Chemical Corporation.
Conclusion
Naoko Inoue's contributions to antiviral research through her patented inventions highlight her role as a leading inventor in the field. Her work not only showcases her innovative spirit but also holds the potential to impact the future of antiviral therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile